A detailed history of Ameritas Advisory Services, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Ameritas Advisory Services, LLC holds 13,793 shares of ARDX stock, worth $69,102. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,793
Previous 13,793 -0.0%
Holding current value
$69,102
Previous $95,000 25.26%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$5.28 - $7.57 $9,947 - $14,261
1,884 Added 15.82%
13,793 $95,000
Q1 2024

May 14, 2024

BUY
$6.05 - $9.74 $72,049 - $115,993
11,909 New
11,909 $86,000
Q3 2023

Nov 13, 2023

BUY
$3.3 - $4.83 $62,647 - $91,692
18,984 New
18,984 $77,000
Q1 2023

Apr 28, 2023

BUY
$2.68 - $4.79 $19,162 - $34,248
7,150 Added 60.42%
18,984 $90,000
Q4 2022

Feb 10, 2023

BUY
$1.22 - $2.85 $14,437 - $33,726
11,834 New
11,834 $33,000

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $775M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Ameritas Advisory Services, LLC Portfolio

Follow Ameritas Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Advisory Services, LLC with notifications on news.